- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Increasing trial participation for new cancer treatments
- Ontologies – what do they have to do with pharma research?
- Fighting the stigmatization of monkeypox patients
- Mobilizing against monkeypox
- Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report
- Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win
- 'Extreme disappointment': With FDA snub of Akebia's vadadustat, another oral anemia med bites the dust
- Senate blesses bill to wrest US supply chains from China's grasp, with pharma front and center